Gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Part 1: Qualitative Research ??Inclusion Criteria for Healthcare Providers:?? 1. Practicing in gastrointestinal surgery for >=10 years; 2. Possessing strong communication skills; 3. Willingness to provide informed consent, voluntarily participate in the study, and undergo audio-recorded interviews. ??Inclusion Criteria for Patients:?? 1. Pathologically confirmed gastric cancer diagnosis with total gastrectomy performed; 2. Diagnosed with sarcopenia based on the ??Asian Working Group for Sarcopenia (AWGS) consensus criteria??: ??(1) Reduced muscle mass??: Appendicular skeletal muscle mass index (ASMI) adjusted for height (measured via dual-energy X-ray absorptiometry, DXA) <5.4 kg/m^2 for females or <7.0 kg/m^2 for males; ??(2) Slow gait speed??: 6-meter usual walking speed <0.8 m/s; ??(3) Weak grip strength??: <18 kg for females or <26 kg for males. Diagnosis requires either: (1)(2), (1)(2)(3), or (1)(3). 3. No prior treatment for gastric cancer; 4. Aged 18–80 years. ??Part 2: Intervention Study? 1. Patients who have been pathologically diagnosed with gastric cancer and have undergone total gastrectomy; 2. Patients who are screened for sarcopenia for the first time (the diagnosis of sarcopenia is confirmed according to the 2014 Asian Working Group's consensus criteria for the diagnosis of sarcopenia in Asia); 3. Patients who have not undergone any gastric cancer treatment before; 4. Patients aged 18 to 80 years old; 5. Patients who can communicate normally; 6. Patients who are willing to participate in the study and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: Part 1: Qualitative Research 1. History of psychiatric disorders; 2. Severe systemic diseases (e.g., severe cardiac, pulmonary, hepatic, or renal dysfunction); 3. Diagnosis of dementia; 4. Inability to cooperate with study requirements. Part 2: Intervention Study? 1. Patients who have developed complications immediately after surgery that affect the method of intervention; 2. Patients who have not undergone the first follow-up as required; 3. Patients with a history of mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative length of stay;Weight;Skeletal Muscle Mass Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Albumin;Prealbumin ;Hemoglobin;Grip strength; | — |
Countries
China
Contacts
Fudan University Shanghai Cancer Center